Analysis of the association between APOA5 polymorphism and cholesterol lowering effects among statin users with hypercholesterolemia from HUSM, Kelantan

Statins, HMG-CoA reductase inhibitors, have shown their efficacy in reducing one of the major risk factors for the disease i.e., the plasma cholesterol level. Patients’ responses to statin therapy have, however, been found to vary significantly. The interindividual variation can be attributed to...

Full description